Newsroom

Press Release
VectorBuilder supports first gene therapy trial for Menkes disease
VectorBuilder Inc. – a global leader in gene delivery technologies – has announced that its partnership with cell and gene therapy company Lantu Biopharma has led to the first human trial of an innovative gene therapy drug candidate for Menkes disease. Read More ››
Press Release
Stand Up Therapeutics signed with VectorBuilder for world’s first gene therapy supply for paraplegia patient
Stand Up Therapeutics Co., Ltd, located in South Korea, is a gene therapy company for paralyzed patients with spinal cord injury. Stand Up Therapeutics announced on July 21 that it had signed an agreement with VectorBuilder Inc., a global leader in gene delivery solutions, to manufacture a GMP grade gene delivery system. Read More ››
Press Release
VectorBuilder to invest $30 million to build the world’s first ‘AAV Superbank’
VectorBuilder has announced its plan to invest $30 million to build an ‘AAV Superbank’ for the research and drug discovery community. Read More ››
Press Release
VectorBuilder to Expand with $500 Million ‘Gene Delivery Research and Manufacturing Campus’
VectorBuilder Inc. – a global leader in gene delivery solutions – has announced the construction of a new R&D and manufacturing center in Guangzhou, China. The ‘Gene Delivery Research and Manufacturing Campus’ will significantly expand VectorBuilder’s R&D capabilities and its production capacity for both research-use and cGMP-grade gene delivery vectors, allowing the company to continue supporting groundbreaking research worldwide. Read More ››
Press Release
VectorBuilder-Pall Partnership Creates Viral Vector Optimization Center
As we rapidly expand from a pure research focus into the clinical market, this partnership will help the company to create optimized, efficient and automated GMP manufacturing platforms. Read More ››
Press Release
VectorBuilder & Landau Enter into Strategic Partnership to Establish World’s First Primate Gene Therapy R&D Center
VectorBuilder Inc., a global leader in vector design, optimization and GMP manufacturing, and Landau Biotechnology Co., a world leader in developing nonhuman primate (NHP) models for clinical research applications, have signed a strategic partnership that will establish the world’s first primate gene therapy R&D center. Read More ››
Press Release
Announcement on Strategic Partnership with Univercells Technologies
“We are extremely pleased to be partnering with Univercells Technologies to co-develop optimized, scalable and customizable solutions for fast and affordable production of viral vectors. This partnership is an important step in VectorBuilder’s ambition to become a global leader in high performance, commercial-scale biomanufacturing,” said Dr Jason Ye, Vice President of Biomanufacturing at VectorBuilder. Read More ››
Interview
VectorBuilder in Japan
Dr. Miho Matakatsu, Managing Director of VectorBuilder Japan, was recently interviewed by JETRO (Japan External Trade Organization) to share VectorBuilder’s success stories in Japan. Read More ››
You can order various molecular cloning services through Design My Vector or Send Design Request on the homepage. You can find our available services and products on the menu bar.
Please let us know what you would like to hear from us about the latest technologies or discoveries by leaving a feedback or contacting us.